Role of dihydrotestosterone in androgen action

Prostate

Volumn 28, Issue 3 SUPPL. 6, 1996, Pages 88-92

  Wilson, Jean D ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

benign prostatic hyperplasia; male pseudohermaphroditism; steroid 5 reductase

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

CONFERENCE PAPER; ENZYME INHIBITION; GENE MUTATION; HORMONE ACTION; HORMONE BINDING; HUMAN; MALE; MALE PSEUDOHERMAPHRODITISM; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TESTOSTERONE METABOLISM;

EID: 0029940805     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0045(1996)6+<88::aid-pros17>3.0.co;2-n     Document Type: Conference Paper

References (32)

1. Tausk M: Androgens and anabolic steroids. In Parnham MJ, Bruinvels J (eds): "Discoveries in Pharmacology, Vol. 2: Haemodynamics, Hormones & Inflammation." Amsterdam: Elsevier, 1984, pp 307-320.
2. David K, Dingemanse E, Freud J, Laqueur E: Uber krystallinisches mannliches Hormon aus Hoden (Testosteron), wirksamer als aus Harn oder aus Cholesterin bereitetes Androsteron. Hoppe Seylers Z Physiol Chem 233:281-282, 1935.
3. 4-3-ketosteroids by rat liver enzymes. In: "Third International Congress of Endocrinology, Mexico, DF, 1968, (International Congress Series 157)." Amsterdam: Excerpta Med Found, 1968, pp 105-106.
4. Saunders FJ: Some aspects of relation of structure of steroids to their prostate stimulating effects. US Natl Cancer Inst Monog 12:139-159, 1964.
5. Segaloff A, Gabbard RB: 5α-androstane - An adrogenic hydrocarbon. Endocrinology 67:887-889, 1960.
6. Farnsworth WE, Brown JR: Metabolism of testosterone by the human prostate. JAMA 183:436-439, 1963.
7. Bruchovsky N, Wilson JD: The conversion of testosterone to 5α-androstan-17β-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem 243:2012-2021, 1968.
8. Anderson KM, Liao S: Selective retention of dihydrotestosterone by prostatic nuclei. Nature 219:277-279, 1968.
9. Wilson JD: Localization of the biochemical site of action of testosterone on protein synthesis in the seminal vesicle of the rat. J Clin Invest 41:153-161, 1962.
10. Wilson JD, Loeb PM: Estrogen and androgen control of cell biosynthesis in target organs. In: "Developmental and Metabolic Control Mechanisms and Neoplasia, 19th Annual Symposium on Fundamental Cancer Research." Baltimore: Williams & Wilkins, 1965, pp 375-390.
11. Bruchovsky N, Wilson JD: The intranuclear binding of testosterone and 5α-androstan-17β-ol-3-one by rat prostate. J Biol Chem 243:5953-5960, 1968.
12. Fang S, Anderson KM, Liao S: Receptor proteins for androgens: On the role of specific proteins in selective retention of 17β-hydroxy-5α-androstan-3-one by rat ventral prostate in vivo and in vitro. J Biol Chem 244:6584-6595, 1969.
13. Wilson JD: Metabolism of testicular androgens. In Creep RO, Astwood EB (eds): "Handbook of Physiology. Endocrinology, Male Reproductive System," Vol. V, Sec. 7. Washington, DC: American Physiological Society, 1975, pp 491-508.
14. Bruchovsky N: Comparison of the metabolites formed in rat prostate following the in vivo administration of seven natural androgens. Endocrinology 89:1212-1222, 1971.
15. Jost A: Problems of fetal endocrinology: The gonadal and hypophyseal hormones. Recent Prog Horm Res 8:379-418, 1953.
16. Wilson JD, Lasnitzki I: Dihydrotestosterone formation in fetal tissues of the rabbit and rat. Endocrinology 89:659-668, 1971.
17. Siiteri PK, Wilson JD: Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 38:113-125, 1974.
18. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, Mac-Donald PC, Wilson JD: Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 291:944-949, 1974.
19. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE: Steroid 5α-reductase deficiency in man: An inherited form of male pseudohermaphroditism. Science 186:1213-1215, 1974.
20. Wilson JD, Griffin JE, Russell DW: Steroid 5α-reductase 2 deficiency. Endocr Rev 14:577-593, 1993.
21. Andersson S, Bishop RW, Russell DW: Expression cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 264:16249-16255, 1989.
22. Andersson S, Berman DM, Jenkins EP, Russell DW: Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354:159-161, 1991.
23. Russell DW, Wilson JD: Steroid 5α-reductase: Two genes/two enzymes. Annu Rev Biochem 63:25-61, 1994.
24. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW: Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 92:903-910, 1993.
25. Wilson JD: The pathogenesis of benign prostatic hyperplasia. Am J Med 68:745-756, 1980.
26. Rittmaster RS: Finasteride. N Engl J Med 330:120-125, 1994.
27. Wenderoth UK, George FW, Wilson JD: The effect of a 5α-reductase inhibitor on androgen-mediated growth of the dog prostate. Endocrinology 113:569-573, 1983.
28. Ito T, Horton R: The source of plasma dihydrotestoster-one in man. J Clin Invest 50:1621-1627, 1971.
29. Deslypere J-P, Sayed A, Verdonck L, Vermeulen A: Androgen concentrations in sexual and non-sexual skin as well as in striated muscle in man. J Steroid Biochem 13:1455-1458, 1980.
30. Liao S, Fang S: Receptor-proteins for androgens and the mode of action of androgens on gene transcription in ventral prostate. Vitam Horm 27:18-90, 1969.
31. Grino PB, Griffin JE, Wilson JD: Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 126:1165-1172, 1990.
32. Deslypere J-P, Young M, Wilson JD, McPhaul MJ: Testosterone and 5α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol Cell Endocrinol 88:15-22, 1992.